Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose
not so with this long acting version
You shouldnt take tirzepatide medications or Wegovy if you have: A personal or family history of medullary thyroid carcinoma (MTC) A history of multiple endocrine neoplasia syndrome type 2 (MEN 2) A serious allergic reaction to tirzepatide, semaglutide , or any of the ingredients in these medications Your clinician will determine if GLP-1 medications are right for you if you have a history of: Pancreatitis , kidney problems, or gallbladder disease, including gallstones Diabetic retinopathy Gastroparesis or other serious digestive conditions Tirzepatide and Wegovy are also not for people who are pregnant, planning to become pregnant, or breastfeeding
At maintenance doses of 2.0mg or 2.4mg, the volume increases significantly
If gastrointestinal side effects become problematic, your PlexusDx clinical team can explore alternatives like oral tirzepatide (is $349/mo month-to-month (or $279/mo on the 6-month plan)) or GLP-Squared Injection ($289/mo), which combines semaglutide and tirzepatide for dual-pathway activation without necessarily higher side effect burdens